Strength
6 mg/24h
Manufacturer
UCB, Inc.NDC
50474080503
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
1/1/2026
Active Ingredients
ROTIGOTINEApproval Type
New Drug (NDA)
FDA Application
NDA021829On Market Since
4/2/2012
Pharmacological Classes
Dopamine Agonists
Nonergot Dopamine Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.